November 6, 2019—Inari Medical, Inc. announced the presentation of early outcomes from CLOUT, the ClotTriever Outcomes Registry evaluating the company’s ClotTriever mechanical thrombectomy system for treatment of acute and chronic lower extremity deep vein thrombosis (DVT).
The initial results for the first 50 patients in the registry were presented by Principal Investigator David J. Dexter, MD, in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.
Inari’s ClotTriever system is designed to remove large clot volume from large veins. The procedure does not require use of thrombolytic drugs. The ClotTriever system received FDA 510(k) clearance for the nonsurgical removal of thrombus from the peripheral vasculature.
According to the company, CLOUT is a 500-patient prospective, multicenter, single-arm registry evaluating real-world patient outcomes after treatment of lower extremity DVT with ClotTriever. The study has no exclusions for age of clot. Three-quarters of patients presented with clot > 2 weeks old. More than half of patients failed other therapies before treatment.
Investigators removed thrombus in all patients, and more than three-quarters of patients met the study's primary effectiveness endpoint of near-complete clot resolution. No patients received thrombolytics, no bleeding complications were reported, and no procedure- or device-related major adverse events were reported. Average blood loss was < 30 mL.
Dr. Dexter commented in Inari’s announcement, "Early results from the first 50 patients enrolled in CLOUT are encouraging with 76% of patients free from postthrombotic syndrome (PTS) within 30 days of treatment. We may finally have the tools to truly test the hypothesis that early resolution of venous thrombus in DVT patients may prevent PTS."
advertisement
Featured Video
From tortuosity to GSV, Varithena® can.
Sponsored by BTG International Group.
Related Articles
Top 5 Articles From October 2019
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
Top 5 from CIToday's Current Issue
Meeting the Challenge…
By Azeem Latib, MD
Massive Thromboembolism, PFO, and Acute Limb Ischemia
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
Radial Access for the Evaluation of Bypass Grafts
By Moderator: Mirvat Alasnag, MD, FACP, FSCAI, FRCP
Panelists: James Nolan, MBChB, FRCP, MD; Sunil Rao, MD; and Binita Shah, MD, MS, FACC, FSCAI
Compensation and Production Trends for Interventionalists
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
